HIGHLY ACTIVE ANTICANCER CURCUMIN ANALOGUES
Author:
Publisher
Springer US
Link
http://link.springer.com/content/pdf/10.1007/978-0-387-46401-5_2.pdf
Reference80 articles.
1. 1. B. J. Druker, C. L. Sawyers, H. Kantarjian, D. J. Resta, S. F. Reese, J. M. Ford, R. Capdeville, and M. Talpaz, Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 344(14), 1038–1042 (2001).
2. 2. M. A. Cobleigh, C. L. Vogel, D. Tripathy, N. J. Robert, S. Scholl, L. Fehrenbacher, J. M. Wolter, V. Paton, S. Shark, G. Lieberman, and D. J. Slamon, Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol 17(9), 2639–2648 (1999).
3. 3. R. B. Weiss, R. C. Donehower, P. H. Wiernik, T. Ohnuma, R. J. Gralla, D. L. Trump, J. R. Baker, Jr., D. A. Van Echo, D. D. Van Hoff, and B. Leyland-Jones, Hypersensitivity reactions from taxol. J Clin Oncol 8(7), 1263–1268 (1990).
4. 4. E. A. Eisenhauer, W. W. ten Bokkel Huinink, K. D. Swenerton, L. Gianni, J. Myles, M. E. van der Burg, I. Kerr, J. B. Vermorken, K. Buser, and N. Colombo, European–Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high dose versus low-dose and long versus short infusion. J Clin Oncol 12(12), 2654–2666 (1994).
5. 5. D. Raghavan, B. Koczwara, and M. Javle, Evolving strategies of cytotoxic chemotherapy for advanced prostate cancer. Eur J Cancer 33(4), 566–574 (1997).
Cited by 103 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Activation of autophagy promotes the inhibitory effect of curcumin analog EF‐24 against MDA‐MB‐231 cancer cells;Journal of Biochemical and Molecular Toxicology;2024-01-19
2. Wnt/β-catenin signaling pathway in the tumor progression of adrenocortical carcinoma;Frontiers in Endocrinology;2024-01-09
3. Anticarcinogenic Potency of EF24: An Overview of Its Pharmacokinetics, Efficacy, Mechanism of Action, and Nanoformulation for Drug Delivery;Cancers;2023-11-20
4. Inhibition of autophagic flux by the curcumin analog EF‐24 and its antiproliferative effect on MCF‐7 cancer cells;Journal of Biochemical and Molecular Toxicology;2023-01-12
5. Herbal Drugs in Cancer Treatment;Russian Journal of Bioorganic Chemistry;2022-10-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3